Results Compared with control group, GSH induced better outcomes, including superior graft retention, appearance, and histological structures
Additionally, we analyze its potential as multidisease biomarker, crosstalk mediator, and therapeutic target, providing new strategies and perspectives for drug research and the prevention and treatment of various diseases
It might be challenging to compare DPP-4 inhibitors and GLP-1 receptor agonists in pasireotide-induced hyperglycemia
While berberine offers metabolic support, it is significantly less potent than GLP-1 medications for weight loss and blood sugar control
Welles, J
Athletes subject to WADA, USADA, NCAA, or equivalent testing cannot use BPC-157 in any form